Autologous bone marrow mononuclear cells (Universidade Federal do Rio de Janeiro)

自体骨髓单个核细胞(里约热内卢联邦大学)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAutologous bone marrow mononuclear cells (Universidade Federal do Rio de Janeiro)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsSilicosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Brazil
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Brazil
Active IndicationsN/A
Inactive IndicationsSilicosis

Other Information

ATC CodeN/A
Related LinksN/A